The global Dural Graft Market is on the verge of witnessing a drastic In Upcoming Years. The digital renaissance is dictating the terms for the industry. AI-powered data core is being used for delivering insights. Also, the virtual workforce is being developed with a transfer of digital skills, that too, from a plethora of innovative ecosystems and industries. Conversational AI is being deployed for helping the end-users with timely feedback. This trend is bound to take the overall industry at a greater stride in the upcoming period.
Global demand for dural graft is expected to grow significantly, owing to rising burden of neurosurgical diseases leading to increasing cranial and spinal duraplasty, and rapid technological advancements in dural graft products.
Moreover, increasing global neurosurgical workforce, extensive clinical research, and increasing demand for CNS dural repair are responsible for increasing the adoption of dural graft products.
Planning Forward? Access Sample Of Dural Graft Market Report! https://www.persistencemarketresearch.com/samples/25285
Company Profiles
- Cook Medical.
- Integra Lifesciences Corporation
- B Braun
- Cousin Biotech,
- Natus Medical Incorporated
- Tissuemed Ltd,
- Vostra GmbH
- Stryker Corporation
- Medtronic Plc.
- Johnson & Johnson,
- Aesculap, Inc.
- Baxter International Inc
For instance, in 2004, the World Health Organization (WHO) estimated that, there were 33,193 neurosurgeons worldwide, including trainees. Whereas, in 2015, this number rose to approximately 49,940 neurosurgeons, with a 4% total growth, worldwide.
Get A Customized Scope To Match Your Need Ask An Expert – sales@persistencemarketresearch.com
Persistence Market Research predicts that, the global dural graft market will exhibit a 6% CAGR during the forecast period (2019-2029).
Key Takeaways of Dural Graft Market Study
- By product type, synthetic dural graft along with xenogeneic dural graft are expected to gain traction during the forecast period.
- Technological advancements in material science of dural graft products in North America and Europe are expected to contribute to the significant dominance of these regions during the forecast period.
- Brain and spine tumor applications are expected to hold more than 50% share in the global dural graft market.
- Synthetic polymer material is expected to gain significant traction and experience 2X demand by 2029.
- Leading dural graft manufacturing companies are partnering with innovative product developers and specialized distributors to strengthen their market position.
- Rising healthcare expenditure and increasing neurosurgeon workforce density in East Asia are expected to offer significant opportunities for market growth.
How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Dural Graft Market? https://www.persistencemarketresearch.com/methodology/25285
“Increasing scientific evidence from industry-led clinical trials and technological advancements in dural graft products are expected to support the significant adoption of synthetic nanofibrous dural grafts.” says a PMR analyst.
Brain and Spinal Tumor Application Dominating Dural Graft Market
Prevalence of CNS tumors due to neurological conditions is growing rapidly. Chiari malformation and spinal cord tumor-related neurosurgical procedures requiring dural grafts for surgeries are becoming more frequent. Growing risk of such neurological conditions demands neurosurgical procedures along with duraplasty for effective and safe treatment outcomes.
For instance, in 2018, more than 50% of dural grafts were used in cranial and spine tumor operations. This high proportion is estimated to continue in the future.
Planning To Introduce An Offbeat Product/Technology In The Dural Graft Market? Go To “Purchase Now” To Have Our Dural Graft Market Report! https://www.persistencemarketresearch.com/checkout/25285
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the dural graft market in its latest study, presenting historical demand assessment from 2014-2018 and projections for 2019-2029, on the basis of product type (xenogeneic dural graft, synthetic dural graft, autologous dural graft, and allogeneic dural graft), application (brain and spine tumor, traumatic brain and spine injury, cerebrospinal fluid (CSF) accumulation, cerebrovascular accident, epilepsy, and others), material (bovine pericardium, autologous pericardium, synthetic polymers, ligamentum nuchae, and others), and end user (hospitals, ambulatory surgical centers, trauma centers, and clinics), across seven key regions.
Related Reports:
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Japan Office: 1-2-1 Kinshi Arca Central Building
14/F Tokyo, 130-0013, Japan
Call 1-888-863-3700
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com